Home > Insider Trading > Filing (0001883850-22-000046)

Filing Details

Accession Number:: 0001883850-22-000046
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-18 16:05:01
Reporting Period:: 2022-05-16

Accepted Time:: 2022-05-18 16:05:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1796226	J Andrew Murphy	777 Old Saw Mill River Road Tarrytown NY 10591	Evp Research	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-05-16	10,000	$179.13	68,470	No	4	M	Direct
Common Stock	Disposition	2022-05-16	6,457	$648.31	62,013	No	4	F	Direct
Common Stock	Disposition	2022-05-17	59	$655.40	61,954	No	4	S	Direct
Common Stock	Disposition	2022-05-17	58	$656.52	61,896	No	4	S	Direct
Common Stock	Disposition	2022-05-17	60	$657.51	61,836	No	4	S	Direct
Common Stock	Disposition	2022-05-17	123	$658.56	61,713	No	4	S	Direct
Common Stock	Disposition	2022-05-17	77	$660.32	61,636	No	4	S	Direct
Common Stock	Disposition	2022-05-17	465	$661.46	61,171	No	4	S	Direct
Common Stock	Disposition	2022-05-17	779	$662.57	60,392	No	4	S	Direct
Common Stock	Disposition	2022-05-17	472	$663.60	59,920	No	4	S	Direct
Common Stock	Disposition	2022-05-17	428	$664.32	59,492	No	4	S	Direct
Common Stock	Disposition	2022-05-17	126	$665.36	59,366	No	4	S	Direct
Common Stock	Disposition	2022-05-17	352	$666.23	59,014	No	4	S	Direct
Common Stock	Disposition	2022-05-17	154	$667.49	58,860	No	4	S	Direct
Common Stock	Disposition	2022-05-17	180	$668.68	58,680	No	4	S	Direct
Common Stock	Disposition	2022-05-17	153	$669.12	58,527	No	4	S	Direct
Common Stock	Disposition	2022-05-17	57	$670.49	58,470	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2022-05-16	10,000	$0.00	10,000	$179.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2022-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,285	Indirect	By 401(k) Plan

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 77 shares of Company stock on May 17, 2022 at prices ranging from $660.18 to $660.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 465 shares of Company stock on May 17, 2022 at prices ranging from $661.16 to $661.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 779 shares of Company stock on May 17, 2022 at prices ranging from $662.29 to $662.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 472 shares of Company stock on May 17, 2022 at prices ranging from $663.20 to $663.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 428 shares of Company stock on May 17, 2022 at prices ranging from $664.01 to $664.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 352 shares of Company stock on May 17, 2022 at prices ranging from $666.11 to $666.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 154 shares of Company stock on May 17, 2022 at prices ranging from $667.27 to $667.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 180 shares of Company stock on May 17, 2022 at prices ranging from $668.41 to $668.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
Represents volume-weighted average price of sales of 153 shares of Company stock on May 17, 2022 at prices ranging from $669.00 to $669.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2022 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.